INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

21,588 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$117K
6,500 sh
Apr 14, 2026Apr 15, 2026
Page 328 of 540
← PrevNext →
traded Apr 14, 2026
+1d
SEC Form 4

Evidence

19
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$117K
6,500 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

19
TH
Tarbert HeathPresident
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$160K
1,645 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

19
TH
Tarbert HeathPresident
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
556 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

19
TH
Tarbert HeathPresident
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
600 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

19
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
5,500 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

19
TH
Tarbert HeathPresident
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$81K
900 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

19
TH
Tarbert HeathPresident
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
608 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

19
TH
Tarbert HeathPresident
CRCLCircle Internet Group, Inc.
Open-market sale · 10b5-1 plan
SELL$250K
2,623 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

19
CK
Cramer KeithChief Revenue Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$97K
10.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

16
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$370
9 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

16
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
1,014 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

16
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1,875
65 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

16
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$853
20 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

15
KL
Kutua LubiCFO, Treasurer
BYNDBEYOND MEAT, INC.
Open-market sale · 10b5-1 plan
SELL$253K
419.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

15
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$617K
14.1K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

15
MA
Murray Michael AndrewDirector, CEO
KOPNKOPIN CORP
Open-market sale · 10b5-1 plan
SELL$526K
187.9K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

14
Siebel Thomas MDirector, Executive Chairman, 10% Owner
AIC3.ai, Inc.
Open-market sale · 10b5-1 plan
SELL$1.40M
165.3K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
4,000 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
4,000 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
4,000 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
1,018 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$373K
14.1K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
550 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
155 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

12
BG
Bexiga Annabelle GDirector
SNEXStoneX Group Inc.
Open-market sale · 10b5-1 plan
SELL$153K
1,500 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

12
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$626K
30.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

11
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$353K
7,921 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

10
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$176K
6,348 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

9
RH
Robinson Mark HaymondGeneral Counsel and Secretary
GMEGameStop Corp.
Open-market sale · 10b5-1 plan
SELL$91K
3,912 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
IC
Indelicarto Thomas CEVP, Gen Counsel & Secretary
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$134K
498 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

9
PJ
Pernice Thomas JDirector
TPETTrio Petroleum Corp
Open-market sale · 10b5-1 plan
SELL—
25.0K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

9
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$422K
15.7K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

8
ML
Mater Tonya L.SVP & Chief Accounting Officer
EPREPR PROPERTIES
Open-market sale · 10b5-1 plan
SELL$112K
2,000 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

8
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$889K
9,583 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

7
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$302K
2,369 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

7
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$698K
5,432 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

7
BL
Brooks Jayme L.Chief Financial Officer
LMBLimbach Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
5,703 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

5
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
900 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

4
HM
Hoffmann MartinCEO
ONONOn Holding AG
Open-market sale · 10b5-1 plan
SELL$141K
4,150 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence